TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
An update from Jenscare Scientific Co. Ltd. Class H ( (HK:9877) ) is now available.
Jenscare Scientific Co., Ltd. announced the successful completion of the first batch of commercial implantations of its Ken-Valve, a transcatheter aortic valve replacement system, in various hospitals across China. This milestone marks the beginning of Ken-Valve’s commercial application and is a significant step in the company’s commercialization strategy. Jenscare plans to expand its sales network and optimize production to enhance global commercialization efforts for its core products, including Ken-Valve and LuX-Valve series.
More about Jenscare Scientific Co. Ltd. Class H
Jenscare Scientific Co., Ltd. is a company based in the People’s Republic of China, specializing in medical devices with a focus on transcatheter aortic valve replacement (TAVR) systems. Their primary product, Ken-Valve, is designed to treat severe aortic regurgitation and aortic stenosis, addressing unmet clinical needs in the market.
Average Trading Volume: 1,031,681
Technical Sentiment Signal: Buy
Current Market Cap: HK$4.91B
For detailed information about 9877 stock, go to TipRanks’ Stock Analysis page.